Valuation: Bayer AG

Market Cap 47.85B 55.22B 45.23B 41.06B 76.96B 5,297B 77.42B 540B 209B 2,687B 207B 203B 8,564B P/E 2026 *
22x
P/E 2027 * 15.9x
Enterprise Value 77.81B 89.78B 73.54B 66.76B 125B 8,613B 126B 878B 339B 4,369B 337B 330B 13,925B EV / Sales 2026 *
1.7x
EV / Sales 2027 * 1.59x
Free-Float
99.99%
Yield 2026 *
0.33%
Yield 2027 * 1.15%
1 week-0.32%
Current month-0.36%
1 month+2.24%
3 months+36.28%
6 months+21.95%
Current year+32.46%
1 week 47.74
Extreme 47.74
50.32
1 month 47.44
Extreme 47.445
50.32
3 years 18.39
Extreme 18.39
53.9
5 years 18.39
Extreme 18.39
67.99
Manager TitleAgeSince
Chief Executive Officer 60 01/06/2023
Director of Finance/CFO 57 01/06/2026
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 61 01/04/2017
Chairman 68 28/04/2020
Change 5-day change 1-year change 3-year change Capi.($)
+0.32%+1.15%+82.31%-0.85% 55.25B
+0.43%+1.37%+49.03%+99.48% 1,013B
+0.18%+0.07%+51.47%+64.51% 644B
-0.01%+4.86%+21.66%+70.91% 465B
+0.53%+4.26%+40.29%+40.53% 352B
+0.39%+2.35%+17.96%+24.19% 264B
+0.17%+4.17%+6.96%+13.12% 253B
+0.60%-3.54%+38.20%+43.42% 203B
-1.20%-5.64%-24.09%-58.09% 188B
+1.56%+1.75%+33.68%+95.98% 181B
Average +0.27%-1.08%+31.75%+39.32% 395.97B
Weighted average by Cap. +0.29%+0.01%+35.21%+59.26%

Financials

2026 *2027 *
Net sales 45.78B 52.82B 43.27B 39.28B 73.62B 5,067B 74.06B 517B 200B 2,570B 198B 194B 8,192B 46.99B 54.22B 44.41B 40.32B 75.56B 5,201B 76.02B 530B 205B 2,638B 204B 199B 8,409B
Net income 2.14B 2.47B 2.02B 1.84B 3.44B 237B 3.47B 24.17B 9.34B 120B 9.28B 9.08B 383B 2.94B 3.39B 2.78B 2.52B 4.72B 325B 4.75B 33.15B 12.81B 165B 12.73B 12.45B 526B
Net Debt 29.95B 34.56B 28.31B 25.7B 48.17B 3,316B 48.46B 338B 131B 1,682B 130B 127B 5,360B 26.82B 30.95B 25.35B 23.02B 43.14B 2,969B 43.39B 303B 117B 1,506B 116B 114B 4,800B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
-
Date Price Change
16/09/26 49.01 +0.32%
15/09/26 €48.85 -0.85%
14/09/26 €49.27 +2.76%
11/09/26 €47.95 -1.77%
10/09/26 €48.81 -0.71%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
48.71EUR
Average target price
58.22EUR
Spread / Average Target
+19.53%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!